Cargando…
Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma
Tumor cells co-express vascular endothelial growth factor (VEGF) and VEGF receptors (VEGFRs) that interact each other to support a self-sustainable cell growth. So far, this autocrine VEGF loop is not reported in human intrahepatic cholangiocarcinoma (ICC). Apatinib is a highly selective VEGFR2 inhi...
Autores principales: | Peng, Hong, Zhang, Qiuyang, Li, Jiali, Zhang, Ning, Hua, Yunpeng, Xu, Lixia, Deng, Yubin, Lai, Jiaming, Peng, Zhenwei, Peng, Baogang, Chen, Minhu, Peng, Sui, Kuang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941382/ https://www.ncbi.nlm.nih.gov/pubmed/26967384 http://dx.doi.org/10.18632/oncotarget.7948 |
Ejemplares similares
-
Efficacy and Safety of Apatinib in Treatment of Unresectable Intrahepatic Cholangiocarcinoma: An Observational Study
por: Hu, Yubin, et al.
Publicado: (2020) -
Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer
por: Lin, Yi, et al.
Publicado: (2017) -
Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018) -
The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
por: Zhou, Qi, et al.
Publicado: (2013) -
Apatinib as non-first-line treatment in patients with Intrahepatic Cholangiocarcinoma
por: Mao, Jinzhu, et al.
Publicado: (2021)